Delphine BADINAND

Onco-radiotherapist at the Timone Hospital

APHM

MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.

Cancerology is booming and immunotherapy represents the most promising approach. At the APHM we have been at the forefront of these therapeutic advances and as a radiotherapist, I’m developing new strategies combining radiotherapy and immunotherapy to reach the « abscopal effect ». MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.

#clinic

Have a look on our testimonies

MI COMMUNITY

New molecules currently under development at Innate Pharma and in new companies in Marseille reflect the teams' dynamism and local potential.

Norbert VEY
AMU, IPC

MI COMMUNITY

The thrust of MI is the ability of Marseille researchers, clinicians and industrials to play as a team.

Hervé BRAILLY
Innate Pharma

MI COMMUNITY

Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.

Daniel OLIVE
AMU, IPC, CRCM

MI COMMUNITY

Thanks to this unprecedented alliance of researchers, clinicians, technological platforms and industrials we should be able to quickly do much better

Vincent BARLOGIS
AP-HM

MI AND YOU Show
your commitment to MI

Testify